Transcription profiling of Brca1- and p53-deficient mouse mammary tumors to treatment with doxorubicin, docetaxel or cisplatin

ABSTRACT: We have studied in vivo responses of spontaneous Brca1- and p53-deficient mouse mammary tumors to treatment with doxorubicin, docetaxel or cisplatin.

ORGANISM(S): Mus musculus

SUBMITTER: Cor Lieftink 

PROVIDER: E-NCMF-5 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress